Mammalian EGLN genes have distinct patterns of mRNA expression and regulation

被引:163
作者
Lieb, ME [1 ]
Menzies, K [1 ]
Moschella, MC [1 ]
Ni, RJ [1 ]
Taubman, MB [1 ]
机构
[1] CUNY Mt Sinai Sch Med, Dept Med, Michael & Zena A Wiener Cardiovasc Inst, New York, NY 10029 USA
来源
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE | 2002年 / 80卷 / 04期
关键词
EGLN; SM-20; vascular smooth muscle; C2C12; prolyl hydroxylase;
D O I
10.1139/O02-115
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mammalian EGLN family contains three paralagous genes (EGLN1, EGLN2, and EGLN3) encoding prolyl hydroxylase isoforms that mediate the oxygen-dependent targeting of the transcription factor hypoxia inducible factor alpha to the proteosome. The rat orthologue of EGLN3 (SM-20) exhibits tissue-restricted expression, is induced by growth factors in cultured vascular smooth muscle, and is up-regulated during myogenesis. To determine if all three EGLN genes are coordinately regulated, we examined their mRNA expression in murine tissues and in cultured cells. We now report that the three murine EGLN mRNAs have unique but overlapping patterns of tissue expression. The most striking differences were in the heart, where EGLN3 had its highest levels of expression, and the testis, where EGLN2 was the only isoform expressed, In cultured vascular smooth muscle cells, serum treatment led to up-regulation of EGLN1 and EGLN3, but not EGLN2, and only EGLN3 was superinduced by cyclohexamide. In cultured C2C12 myocytes, EGLN3 was up-regulated during differentiation, whereas EGLN1 and EGLN2 were constitutively expressed. The abundance of EGLN3 mRNA in the heart, its induction by growth factors in vascular smooth muscle, and its regulation during C2Cl2 differentiation suggest a unique role for EGLN3 and might justify the development of isoform-specific inhibitors.
引用
收藏
页码:421 / 426
页数:6
相关论文
共 16 条
[1]  
ARAVIND L, 2001, GENOME BIOL, V2
[2]   Mapping, characterization, and expression analysis of the SM-20 human homologue, C1orf12, and identification of a novel related gene, SCAND2 [J].
Dupuy, D ;
Aubert, I ;
Dupérat, VG ;
Petit, J ;
Taine, L ;
Stef, M ;
Bloch, B ;
Arveiler, B .
GENOMICS, 2000, 69 (03) :348-354
[3]   C-elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation [J].
Epstein, ACR ;
Gleadle, JM ;
McNeill, LA ;
Hewitson, KS ;
O'Rourke, J ;
Mole, DR ;
Mukherji, M ;
Metzen, E ;
Wilson, MI ;
Dhanda, A ;
Tian, YM ;
Masson, N ;
Hamilton, DL ;
Jaakkola, P ;
Barstead, R ;
Hodgkin, J ;
Maxwell, PH ;
Pugh, CW ;
Schofield, CJ ;
Ratcliffe, PJ .
CELL, 2001, 107 (01) :43-54
[4]  
GREEN RS, 1995, LAB INVEST, V73, P476
[5]   ONCOGENE-INDUCED TRANSFORMATION OF A RAT EMBRYO FIBROBLAST CELL-LINE IS ENHANCED BY TUMOR PROMOTERS [J].
HSIAO, WLW ;
WU, T ;
WEINSTEIN, IB .
MOLECULAR AND CELLULAR BIOLOGY, 1986, 6 (06) :1943-1950
[6]   Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1α [J].
Iyer, NV ;
Kotch, LE ;
Agani, F ;
Leung, SW ;
Laughner, E ;
Wenger, RH ;
Gassmann, M ;
Gearhart, JD ;
Lawler, AM ;
Yu, AY ;
Semenza, GL .
GENES & DEVELOPMENT, 1998, 12 (02) :149-162
[7]   Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation [J].
Jaakkola, P ;
Mole, DR ;
Tian, YM ;
Wilson, MI ;
Gielbert, J ;
Gaskell, SJ ;
von Kriegsheim, A ;
Hebestreit, HF ;
Mukherji, M ;
Schofield, CJ ;
Maxwell, PH ;
Pugh, CW ;
Ratcliffe, PJ .
SCIENCE, 2001, 292 (5516) :468-472
[8]  
LIPSCOMB EA, 2000, J BIOL CHEM, V1, P1
[9]  
Madden SL, 1996, CANCER RES, V56, P5384
[10]   Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors [J].
Marti, HH ;
Risau, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15809-15814